EUVIMEDEUVIMED entdecken
Crossref

Enhancing Wound Healing Through Placental Tissue-Based Wound Care Among Individuals with Xylazine-Associated Wounds

Artiom Butuc, Shrijal Desai, Rishi Gulati, Ean Hudak, Joel Koshy, Connor Stinson, Rachel Vemula, Peter Clark

The Journal of Healthcare Ethics & Administration · 01.05.2026 · 12 (2) · 1-24

DOI: 10.22461/jhea.6.7169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Healthcare Ethics & Administration, online erschienen am 01.05.2026. Verfasst von Artiom Butuc und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xylazine-adulterated opioids have created complex, treatment-resistant wounds among individuals with opioid use disorder (OUD), posing challenges that traditional wound care inadequately addresses. This study examines placenta-derived biomaterials as a therapeutic intervention for opioid-related chronic wounds, focusing on xylazine-induced tissue damage. A multidisciplinary analysis evaluated the scientific rationale, social implications, financial considerations, and medical applications of placental therapies for opioid-related wound care by synthesizing clinical studies and cost-effectiveness research. Placental tissues contain growth factors, anti-inflammatory cytokines, antimicrobial peptides, and extracellular matrix components that address the pathophysiology of xylazine-induced injuries. Dehydrated human amniotic/chorion membranes achieve 77-92% healing rates within 4-6 weeks, compared with negligible improvement with standard care. A cost analysis shows healing costs of $1,771 per wound with placental therapies, up to $8,800 with conventional treatments. Implementation barriers include inconsistent insurance coverage, social stigma, and limited provider education. Given the vulnerability of people who use drugs (PWUD), the ethical dimensions of informed consent, stigma reduction, and equitable implementation remain central to the adoption of placental therapies. Placental-derived biomaterials offer a cost-effective solution for chronic wounds in OUD. However, successful implementation requires policy interventions including expanded coverage, integration with harm-reduction programs, and enhanced provider training, to ensure equitable access.

Zitieren

APA

Butuc, A., Desai, S., Gulati, R., Hudak, E., Koshy, J., Stinson, C., Vemula, R., & Clark, P. (2026). Enhancing Wound Healing Through Placental Tissue-Based Wound Care Among Individuals with Xylazine-Associated Wounds. The Journal of Healthcare Ethics & Administration, 12(2), 1-24. https://doi.org/10.22461/jhea.6.7169

Vancouver

Butuc A, Desai S, Gulati R, Hudak E, Koshy J, Stinson C, et al. Enhancing Wound Healing Through Placental Tissue-Based Wound Care Among Individuals with Xylazine-Associated Wounds. The Journal of Healthcare Ethics & Administration. 2026;12(2):1-24. doi:10.22461/jhea.6.7169

BibTeX
@article{Butuc2026,
  author = {Butuc, Artiom and Desai, Shrijal and Gulati, Rishi and Hudak, Ean and Koshy, Joel and Stinson, Connor and Vemula, Rachel and Clark, Peter},
  title = {Enhancing Wound Healing Through Placental Tissue-Based Wound Care Among Individuals with Xylazine-Associated Wounds},
  journal = {The Journal of Healthcare Ethics & Administration},
  year = {2026},
  volume = {12},
  number = {2},
  pages = {1--24},
  doi = {10.22461/jhea.6.7169}
}
Kostenlos starten →